Literature DB >> 3193447

A six year experience with recurrent infection and immunodeficiency in children in Kuwait.

A G White1, K T Raju, G M Abouna.   

Abstract

Sixty-five Arab children in Kuwait with recurrent infections were subjected to laboratory investigations to determine their immune function. Twenty (31%) of these children were found to have a primary immunodeficiency syndrome, 36 patients (55%) had laboratory abnormalities but could not be classified, three patients (5%) had other well defined diseases responsible for their laboratory defect, and six patients (9%) had normal laboratory values. The most common infection site was the upper respiratory tract or chest, and the most frequent organisms isolated were Candida albicans, Staphylococcus aureus and Salmonella sp. in patients in whom detailed information was available, 70% had a family history of similar disease and 68% had consanguinous parents. These children represent only a fraction of those that should be investigated and it is recommended that a referral center for the investigation of children with recurrent infection be established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193447

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  3 in total

Review 1.  Genetic testing and genomic analysis: a debate on ethical, social and legal issues in the Arab world with a focus on Qatar.

Authors:  Hatem El Shanti; Lotfi Chouchane; Ramin Badii; Imed Eddine Gallouzi; Paolo Gasparini
Journal:  J Transl Med       Date:  2015-11-14       Impact factor: 5.531

2.  Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).

Authors:  Waleed Al-Herz
Journal:  J Clin Immunol       Date:  2007-11-16       Impact factor: 8.317

3.  Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center.

Authors:  P Benjasupattananan; T Simasathein; P Vichyanond; V Leungwedchakarn; N Visitsunthorn; P Pacharn; O Jirapongsananuruk
Journal:  J Clin Immunol       Date:  2009-01-28       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.